334 related articles for article (PubMed ID: 31020600)
1. Optimizing pharmaceutical care for pediatric patients with dermatitis: perspectives of parents and pharmacy staff.
Koster ES; Philbert D; Wagelaar KR; Galle S; Bouvy ML
Int J Clin Pharm; 2019 Jun; 41(3):711-718. PubMed ID: 31020600
[TBL] [Abstract][Full Text] [Related]
2. Adolescents' Perspectives on Atopic Dermatitis Treatment-Experiences, Preferences, and Beliefs.
Kosse RC; Bouvy ML; Daanen M; de Vries TW; Koster ES
JAMA Dermatol; 2018 Jul; 154(7):824-827. PubMed ID: 29847623
[TBL] [Abstract][Full Text] [Related]
3. Focus group parental opinions regarding treatment with topical corticosteroids on children with atopic dermatitis.
Veenje S; Osinga H; Antonescu I; Bos B; de Vries TW
Allergol Immunopathol (Madr); 2019; 47(2):166-171. PubMed ID: 30316560
[TBL] [Abstract][Full Text] [Related]
4. Corticosteroid Phobia Among Pharmacists Regarding Atopic Dermatitis in Children: A National French Survey.
Raffin D; Giraudeau B; Samimi M; Machet L; Pourrat X; Maruani A
Acta Derm Venereol; 2016 Feb; 96(2):177-80. PubMed ID: 26039683
[TBL] [Abstract][Full Text] [Related]
5. Topical corticosteroid phobia in atopic dermatitis: a study of its nature, origins and frequency.
Aubert-Wastiaux H; Moret L; Le Rhun A; Fontenoy AM; Nguyen JM; Leux C; Misery L; Young P; Chastaing M; Danou N; Lombrail P; Boralevi F; Lacour JP; Mazereeuw-Hautier J; Stalder JF; Barbarot S
Br J Dermatol; 2011 Oct; 165(4):808-14. PubMed ID: 21671892
[TBL] [Abstract][Full Text] [Related]
6. Corticosteroid phobia (corticophobia) in parents of young children with atopic dermatitis and their health care providers.
Bos B; Antonescu I; Osinga H; Veenje S; de Jong K; de Vries TW
Pediatr Dermatol; 2019 Jan; 36(1):100-104. PubMed ID: 30338542
[TBL] [Abstract][Full Text] [Related]
7. Reducing corticosteroid phobia in pharmacy staff and parents of children with atopic dermatitis.
Koster ES; Philbert D; Zheng X; Moradi N; de Vries TW; Bouvy ML
Int J Clin Pharm; 2021 Oct; 43(5):1237-1244. PubMed ID: 33582952
[TBL] [Abstract][Full Text] [Related]
8. Topical corticosteroid phobia among parents of children with atopic dermatitis in a semirural area of Norway.
Gustavsen HE; Gjersvik P
J Eur Acad Dermatol Venereol; 2016 Jan; 30(1):168. PubMed ID: 25174954
[No Abstract] [Full Text] [Related]
9. Pharmacists' knowledge about use of topical corticosteroids in atopic dermatitis: Pre and post continuing professional development education.
Smith SD; Lee A; Blaszczynski A; Fischer G
Australas J Dermatol; 2016 Aug; 57(3):199-204. PubMed ID: 25846602
[TBL] [Abstract][Full Text] [Related]
10. Effect of sequential applications of topical tacrolimus and topical corticosteroids in the treatment of pediatric atopic dermatitis: an open-label pilot study.
Kubota Y; Yoneda K; Nakai K; Katsuura J; Moriue T; Matsuoka Y; Miyamoto I; Ohya Y
J Am Acad Dermatol; 2009 Feb; 60(2):212-7. PubMed ID: 19027990
[TBL] [Abstract][Full Text] [Related]
11. TOPICOP©: a new scale evaluating topical corticosteroid phobia among atopic dermatitis outpatients and their parents.
Moret L; Anthoine E; Aubert-Wastiaux H; Le Rhun A; Leux C; Mazereeuw-Hautier J; Stalder JF; Barbarot S
PLoS One; 2013; 8(10):e76493. PubMed ID: 24146878
[TBL] [Abstract][Full Text] [Related]
12. Comparison of parent knowledge, therapy utilization and severity of atopic eczema before and after explanation and demonstration of topical therapies by a specialist dermatology nurse.
Cork MJ; Britton J; Butler L; Young S; Murphy R; Keohane SG
Br J Dermatol; 2003 Sep; 149(3):582-9. PubMed ID: 14510993
[TBL] [Abstract][Full Text] [Related]
13. Parental knowledge of topical therapies in the treatment of childhood atopic dermatitis.
Beattie PE; Lewis-Jones MS
Clin Exp Dermatol; 2003 Sep; 28(5):549-53. PubMed ID: 12950351
[TBL] [Abstract][Full Text] [Related]
14. Involving the public and other stakeholders in development and evaluation of a community pharmacy alcohol screening and brief advice service.
Krska J; Mackridge AJ
Public Health; 2014 Apr; 128(4):309-16. PubMed ID: 24713598
[TBL] [Abstract][Full Text] [Related]
15. Pediatric medication use experiences and patient counseling in community pharmacies: Perspectives of children and parents.
Abraham O; Brothers A; Alexander DS; Carpenter DM
J Am Pharm Assoc (2003); 2017; 57(1):38-46.e2. PubMed ID: 27843107
[TBL] [Abstract][Full Text] [Related]
16. Atopic dermatitis in children in the United States, 1997-2004: visit trends, patient and provider characteristics, and prescribing patterns.
Horii KA; Simon SD; Liu DY; Sharma V
Pediatrics; 2007 Sep; 120(3):e527-34. PubMed ID: 17766497
[TBL] [Abstract][Full Text] [Related]
17. Topical corticosteroid phobia in patients with atopic eczema.
Charman CR; Morris AD; Williams HC
Br J Dermatol; 2000 May; 142(5):931-6. PubMed ID: 10809850
[TBL] [Abstract][Full Text] [Related]
18. [Corticosteroid phobia in patients with atopic dermatitis].
Jenerowicz D; Czarnecka-Operacz M; Silny W
Wiad Lek; 2005; 58(11-12):607-15. PubMed ID: 16594469
[TBL] [Abstract][Full Text] [Related]
19. Promoting weight management services in community pharmacy: perspectives of the pharmacy team in Scotland.
Weidmann AE; MacLure K; Marshall S; Gray G; Stewart D
Int J Clin Pharm; 2015 Aug; 37(4):599-606. PubMed ID: 25822039
[TBL] [Abstract][Full Text] [Related]
20. The proactive wet-wrap method with diluted corticosteroids versus emollients in children with atopic dermatitis: a prospective, randomized, double-blind, placebo-controlled trial.
Janmohamed SR; Oranje AP; Devillers AC; Rizopoulos D; van Praag MC; Van Gysel D; Goeteyn M; de Waard-van der Spek FB
J Am Acad Dermatol; 2014 Jun; 70(6):1076-82. PubMed ID: 24698702
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
